Patterns of decision making about cancer clinical trial participation among the online cancer treatment community: A collaboration between SWOG and NexCura. This is an ASCO Meeting Abstract from the ...
A randomized, multicenter, phase 3 study of nivolumab vs sorafenib as first-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): CheckMate-459. This is an ASCO Meeting ...
It is estimated that by 2030, 1 in 6 people worldwide will be over 60. Meanwhile, 1 in ten children in the UK are now expected to live beyond 100.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results